Demetrix is a biotechnology company that believes in the power of science to make the world a better place. The company produces effective health and wellness products backed by science, including rare, high-purity cannabinoids for pharmaceutical and consumer applications. Demetrix has a team of industry-leading experts across R&D, production, regulation, and commercialization, with deep experience bringing fermentation products to market. The company is pioneering the study of the more than 100 rare cannabinoids and their interactions with the human body. Demetrix has raised $61 million in venture funding.
HQ: Berkeley, California
Demetrix manufactures natural medicines using synthesis biology. The company uses genetics and computing enabled deciphering technology to produce drugs. It enables refactoring biotechnology microbial hosts for gene synthesis. The company engineers strain to produce co-evolved and bio-inspired medicines and nutraceuticals.